US2005181481A1PendingUtilityA1

HADHs as modifiers of the p21 pathway and methods of use

Assignee: EXELIXIS INCPriority: Jul 12, 2001Filed: Apr 11, 2005Published: Aug 18, 2005
Est. expiryJul 12, 2021(expired)· nominal 20-yr term from priority
G01N 33/57595G01N 33/57575G01N 33/57545G01N 33/57535G01N 33/575G01N 33/5008A01K 2227/706C12Q 1/6886C12Q 2600/158G01N 33/5011G01N 33/5017G01N 33/502G01N 33/5091G01N 33/6872G01N 2333/82G01N 2333/914G01N 2500/10
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Human HADH genes are identified as modulators of the p21 pathway, and thus are therapeutic targets for disorders associated with defective p21 function. Methods for identifying modulators of p21, comprising screening for agents that modulate the activity of HADH are provided.

Claims

exact text as granted — not AI-modified
1 - 25 . (canceled)  
     
     
         26 . An isolated nucleic acid molecule comprising a nucleic acid sequence encoding a polypeptide comprising amino acid residues 9 to 212 of SEQ ID NO:3.  
     
     
         27 . A vector comprising the nucleic acid molecule of  claim 26 .  
     
     
         28 . A host cell comprising the vector of  claim 27 .  
     
     
         29 . A process for producing a protein comprising a polypeptide comprising amino acid residues 9 to 212 of SEQ ID NO:3, said process comprising culturing the host cell of  claim 28  under conditions suitable for expression of said polypeptide and recovering said protein.  
     
     
         30 . An isolated nucleic acid molecule comprising a nucleic acid sequence encoding a polypeptide that is at least 95% identical to amino acid residues 9 to 212 of SEQ ID NO:3.  
     
     
         31 . A vector comprising the nucleic acid molecule of  claim 30 .  
     
     
         32 . A host cell comprising the vector of  claim 31 .  
     
     
         33 . A process for producing a protein comprising a polypeptide comprising amino acid residues 9 to 212 of SEQ ID NO:3, said process comprising culturing the host cell of  claim 32  under conditions suitable for expression of said polypeptide and recovering said protein.  
     
     
         34 . An isolated nucleic acid molecule comprising a nucleic acid sequence that hybridizes under stringent conditions to a second nucleic acid molecule comprising a nucleic acid sequence encoding a polypeptide comprising amino acid residues 9 to 212 of SEQ ID NO:3.  
     
     
         35 . A vector comprising the nucleic acid molecule of  claim 34 .  
     
     
         36 . A host cell comprising the vector of  claim 35 .  
     
     
         37 . A process for producing a protein comprising a polypeptide comprising amino acid residues 9 to 212 of SEQ ID NO:3, said process comprising culturing the host cell of  claim 36  under conditions suitable for expression of said polypeptide and recovering said protein.

Join the waitlist — get patent alerts

Track US2005181481A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.